Jessica Tassan
Stock Analyst at Piper Sandler
(0.38)
# 4,088
Out of 4,396 analysts
220
Total ratings
42%
Success rate
-4.5%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Jessica Tassan
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CTEV Claritev | Maintained: Buy | $90 → $61 | $28.35 | +115.17% | 10 | Jun 3, 2026 | |
| PHR Phreesia | Downgraded: Hold | $34 → $12 | $9.29 | +29.17% | 16 | May 28, 2026 | |
| DOCS Doximity | Reiterated: Buy | $42 | $20.45 | +105.38% | 13 | May 14, 2026 | |
| HUM Humana | Maintained: Hold | $272 → $254 | $363.18 | -30.06% | 7 | May 13, 2026 | |
| HCAT Health Catalyst | Reiterated: Hold | $4 → $2 | $1.71 | +16.96% | 17 | May 12, 2026 | |
| PRVA Privia Health Group | Reiterated: Buy | $36 | $22.17 | +62.38% | 11 | May 8, 2026 | |
| HNGE Hinge Health | Maintained: Buy | $60 → $95 | $62.78 | +51.32% | 6 | May 6, 2026 | |
| UNH UnitedHealth Group | Maintained: Buy | $390 → $420 | $413.00 | +1.69% | 19 | Apr 22, 2026 | |
| CVS CVS Health | Rated: Buy | $101 → $99 | $97.06 | +2.00% | 11 | Mar 31, 2026 | |
| CI The Cigna Group | Reiterated: Buy | $374 → $370 | $295.00 | +25.42% | 6 | Mar 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $30 | $19.20 | +56.25% | 14 | Mar 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $12 → $9 | $6.93 | +29.87% | 22 | Feb 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $49 | $40.69 | +20.42% | 21 | Feb 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $13 → $25 | $27.22 | -8.16% | 8 | Nov 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $18 | $4.72 | +281.36% | 22 | Sep 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $10 → $8 | $8.50 | n/a | 13 | May 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $13 → $10 | $5.05 | n/a | 4 | Jan 17, 2024 |
Claritev
Jun 3, 2026
Maintained: Buy
Price Target: $90 → $61
Current: $28.35
Upside: +115.17%
Phreesia
May 28, 2026
Downgraded: Hold
Price Target: $34 → $12
Current: $9.29
Upside: +29.17%
Doximity
May 14, 2026
Reiterated: Buy
Price Target: $42
Current: $20.45
Upside: +105.38%
Humana
May 13, 2026
Maintained: Hold
Price Target: $272 → $254
Current: $363.18
Upside: -30.06%
Health Catalyst
May 12, 2026
Reiterated: Hold
Price Target: $4 → $2
Current: $1.71
Upside: +16.96%
Privia Health Group
May 8, 2026
Reiterated: Buy
Price Target: $36
Current: $22.17
Upside: +62.38%
Hinge Health
May 6, 2026
Maintained: Buy
Price Target: $60 → $95
Current: $62.78
Upside: +51.32%
UnitedHealth Group
Apr 22, 2026
Maintained: Buy
Price Target: $390 → $420
Current: $413.00
Upside: +1.69%
CVS Health
Mar 31, 2026
Rated: Buy
Price Target: $101 → $99
Current: $97.06
Upside: +2.00%
The Cigna Group
Mar 3, 2026
Reiterated: Buy
Price Target: $374 → $370
Current: $295.00
Upside: +25.42%
Mar 2, 2026
Reiterated: Buy
Price Target: $30
Current: $19.20
Upside: +56.25%
Feb 26, 2026
Reiterated: Buy
Price Target: $12 → $9
Current: $6.93
Upside: +29.87%
Feb 23, 2026
Reiterated: Buy
Price Target: $49
Current: $40.69
Upside: +20.42%
Nov 26, 2025
Upgraded: Buy
Price Target: $13 → $25
Current: $27.22
Upside: -8.16%
Sep 5, 2025
Reiterated: Buy
Price Target: $18
Current: $4.72
Upside: +281.36%
May 23, 2025
Reiterated: Hold
Price Target: $10 → $8
Current: $8.50
Upside: n/a
Jan 17, 2024
Maintained: Hold
Price Target: $13 → $10
Current: $5.05
Upside: n/a